Amneal's Generic Prochlorperazine Edisylate Receives Approval in the U.S.
Viwit Pharm`s Generic Prochlorperazine Edisylate Receives Approval In US
Caplin's Generic Prochlorperazine Edisylate Receives Approval In US
Today’s announcement comes as industry experts work to avoid an extended shortage of Heparin, the preferred anticoagulant for many hospitalized patients. Heparin is commonly prescribed for patients with significant blood clots in their lungs or clogged arteries, and patients receiving dialysis, or undergoing major orthopedic and cardiac surgery. It is prescribed to more than 10 million Americans every year.
Emcure Pharmaceuticals has had its share of run-ins with the FDA in the past over the sterility of one of its Indian manufacturing plants. Now, it can notch one more black mark on its belt.
Two injected drugs manufactured by an Indian company with a history of sterility problems are being recalled because of microbial contamination. The drugs were both manufactured by Emcure Pharmaceuticals but are distributed in the U.S. by Heritage Pharmaceuticals.
Mylan's Generic Prochlorperazine Edisylate Receives Approval in US